LEUKAEMIA BUSTERS
Leukaemia Busters funds potentially life saving research into the development of new improved and safer biologic therapies for patients with haematological malignancies (blood cancers). Leukaemia Busters, formerly a charitable trust registered in 1992 (reg No 1010957) now operates as a charitable incorporated organisation (CIO) since 21 May 2014.
Financial health, per its FY2025 accounts
The accounts state that the charity holds unrestricted reserves of £470,424, which exceeds its stated minimum reserve policy of £100,000. The charity reported a net income surplus of £3,672 for the year, with total funds carried forward increasing to £470,424. The trustees confirm that assets are adequate to meet all existing commitments.
What the accounts disclose
“the trustees have set aside £100,000, more than sufficient for one year’s worth of research funding operations as its minimum reserve.”
“Two trustees were employed by the charity to manage its scientific research programme for the period ended 31st March 2025.” — page 14
Register events
- Received assets from another charity (06/04/2021)
Trustees
- ROBERT WALTER SUTCLIFFE BEdchair
- Angela Marie Lane MSc
- Dr Andrew Charles Lane PhD
- Dr DAVID JOHN FLAVELL PhDFRCPath
- Dr SOPSAMORN UDNOON FLAVELL BSC PHD
- OLIVER JAMES DEVON BA ACA
- Serena Sarah Devon BA
- Shinderpal Singh Shahi BSc
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £70k | £66k |
| 31/03/2024 | £161k | £113k |
| 31/03/2023 | £103k | £109k |
| 31/03/2022 | £94k | £97k |
| 31/03/2021 | £277k | £105k |
Common questions
Is LEUKAEMIA BUSTERS financially healthy?
Per its FY2025 accounts: The accounts state that the charity holds unrestricted reserves of £470,424, which exceeds its stated minimum reserve policy of £100,000. The charity reported a net income surplus of £3,672 for the year, with total funds carried forward increasing to £470,424. The trustees confirm that assets are adequate to meet all existing commitments. Its FY2025 accounts were independently examined.